The Advantages of TURP in Patients with an Elevated/Rising PSA, Mild/Moderate LUTS, Bladder Outlet Obstruction and Negative Prostate Cancer Imaging/Prostate Biopsies. A Prospective Analysis in 105 Consecutive Patients
Journal Title: Open Access Journal of Urology & Nephrology - Year 2016, Vol 1, Issue 1
Abstract
Aim: To investigate elevated/rising PSAas a marker for BOO (Bladder Outlet Obstruction) in patients with minor LUTS (Lower urinary tract Symptoms) and without prostate cancer. Methods: 105 Consecutive patients were prospectively analyzed between 2005 and 2013. All patients were referred to the principal investigator by their general practitioner as a result of an elevated and/or rising PSA. Only patients with minor LUTS (I-PSS (International Prostate Symptom Score) 0-19)) and without suspicion for prostate cancer were included. All patients had BOO, shown by full urodynamics, and underwent TURP. Resected tissue was histologically examined and PSA/IPSS were evaluated after 3, 6 and 12 months and later on yearly. Results: Mean pre-operative PSA- and I-PSS- values were 8.8 ng/mL and 11.1 respectively. The mean detrusor pressure at maximum flow was 93.6 cm H2O. The mean resected volume 52 g and the mean prostatebiopsyrate 1.8. 83/105 patients (79%) had no malignancy and were diagnosed with BOO due to BPH (Benign Prostatic Hyperplasia) (subgroup 1). Their mean PSA decreased from 9.2to 0.7ng/ml and 0.9 ng/ml after 6 and 12 months post-op respectively. The mean IPSS declined from 11 to 3 after 6 months and12months. 16/105 patients (15%) were treated for prostate cancer (subgroup 2). Radical prostatectomy was performed in 11 patients, brachytherapy in 3 patients and external beam radiotherapy in 2 patients. 6/105 Patients (5.7%) had active surveillance (subgroup 3). Conclusion: BOO can cause an elevated/rising PSA in patients with minor LUTS and negative screening for prostate cancer. TURP is an adequate treatment for these patients. Core tip: Patients referred to the urologist because of an elevated/high PSA-value, are a common problem in the daily practice. After excluding prostate cancer or urinary tract infection, patients are reassured. But what has to be done when the PSA-level rises? Our hypothesis suggests that BOO (bladder outlet obstruction) can cause an elevated/high PSA in patients with minor LUTS (I-PSS 0-19) and negative findings for prostate cancer. We describe our findings in 105 consecutive, prospectively enrolled patients and also describe the benefits of a TURP in these patients.
Authors and Affiliations
E. Baten
Keywords
Related Articles
- EP ID EP487063
- DOI 10.23880/oajun-16000105
- Views 73
- Downloads 0
Paradigm Shift of the Strategy on Diabetic Nephropathy in Recent Decade
Almost 20 years ago, it was reported that pancreas transplantation can reverse the lesions of diabetic nephropathy in patients with type 1 diabetes [1] and intensive blood-glucose control decreases the risk of microvascu...
Determination of Homocysteine and Lipid Profile Level in the Blood of Chronic Kidney Disease Patients with and without Hemodialysis in Comparison to Normal Healthy Individuals
Background: Homocysteine a thiol-containing amino acid is an intermediatory product formed in the metabolic conversion of methionine to cysteine. Patients with chronic kidney disease cause many abnormalities in amino aci...
Molecular Mechanism of Pathogenesis and Management of Diabetic Nephropathy
Kidney disease is continuously rising in the society, which may be acute or chronic. The earlier one is attributed to chemical pollution, side effects of drugs/food. The later is mainly due to life style related metaboli...
New Hypoglycaemic Drugs for the Treatment of Diabetes Mellitus and Its Complications: The Future is coming.
Diabetes mellitus (DM) has become a growing epidemic over the last few decades. The International Diabetes Federation (IDF) estimates that more than 640 million people will be affected by this condition by 2040. Although...
Decrease in Quality of Life and Functional Assessment in Elder Patients with End-Stage Renal Disease after Two Years of Hemodialysis Therapy
Introduction: Hemodialysis improves survival rates of Chronic Kidney Disease (CKD) patients but not Quality of Life (QoL) which decreases in a more aggressive way in the elderly population. We describe the reduction and...